UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1–34)] in postmenopausal osteoporosis

Journal of bone and mineral research, 2011-03, Vol.26 (3), p.503-511

2011

Volltextzugriff (PDF)

Hospitalization in High Fracture Risk Older Adults with Osteoporosis Using the Safe Functional Motion Test: A Longitudinal Analysis

Gerontology and geriatric medicine, 2021, Vol.7, p.2333721421998473-2333721421998473

2021

Volltextzugriff (PDF)

Antifracture Efficacy and Reduction of Mortality in Relation to Timing of the First Dose of Zoledronic Acid After Hip Fracture

Journal of bone and mineral research, 2009-07, Vol.24 (7), p.1308-1313

2009

Volltextzugriff (PDF)

Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study

Journal of rheumatology, 2008-03, Vol.35 (3), p.488

2008

Volltextzugriff (PDF)

Bimagrumab to improve recovery after hip fracture in older adults: a multicentre, double-blind, randomised, parallel-group, placebo-controlled, phase 2a/b trial

The Lancet. Healthy longevity, 2021-05, Vol.2 (5), p.e263-e274

2021

Volltextzugriff (PDF)

Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study

BMC musculoskeletal disorders, 2017-04, Vol.18 (1), p.174-174, Article 174

2017

Volltextzugriff (PDF)

Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis

Journal of rheumatology, 2010-01, Vol.37 (1), p.141

2010

Volltextzugriff (PDF)

Romosozumab improves lumbar spine BMD and bone strength greater than alendronate as assessed by quantitative computed tomography and finite element analysis in the ARCH trial

Bone Reports, 2020-10, Vol.13, p.100326, Article 100326

2020

Volltextzugriff (PDF)

Tirzepatide Once Weekly for the Treatment of Obesity

The New England journal of medicine, 2022-07, Vol.387 (3), p.205-216

2022

Volltextzugriff (PDF)

Scores on the safe functional motion test are associated with prevalent fractures and fall history

Physiotherapy Canada, 2013, Vol.65 (1), p.75-83

2013

Volltextzugriff (PDF)

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

The New England journal of medicine, 2021-08, Vol.385 (6), p.503-515

2021

Volltextzugriff (PDF)

Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass

Journal of bone and mineral research, 2017-01, Vol.32 (1), p.181-187

2017

Volltextzugriff (PDF)

Zoledronic acid for prevention and treatment of osteoporosis

Expert opinion on pharmacotherapy, 2011-04, Vol.12 (5), p.807-815

Recknor, Chris

2011

Volltextzugriff (PDF)

Efficacy and safety of transdermal abaloparatide in postmenopausal women with osteoporosis: a randomized study

Journal of bone and mineral research, 2023-10, Vol.38 (10), p.1404-1414

2023

Volltextzugriff (PDF)

Early Effects of Abaloparatide on Bone Formation and Resorption Indices in Postmenopausal Women With Osteoporosis

Journal of bone and mineral research, 2021-04, Vol.36 (4), p.644-653

2021

Volltextzugriff (PDF)

The Efficacy and Safety of Abaloparatide‐SC in Men With Osteoporosis: A Randomized Clinical Trial

Journal of bone and mineral research, 2022-12, Vol.37 (12), p.2435-2442

2022

Volltextzugriff (PDF)

Denosumab compared with ibandronate in postmenopausal women previously treated with bisphosphonate therapy: a randomized open-label trial

Obstetrics and gynecology (New York. 1953), 2013-06, Vol.121 (6), p.1291-1299

2013

Volltextzugriff (PDF)

Zoledronic Acid for the Prevention of Bone Loss in Postmenopausal Women With Low Bone Mass: A Randomized Controlled Trial

Obstetrics and gynecology (New York. 1953), 2009-11, Vol.114 (5), p.999-1007

2009

Volltextzugriff (PDF)

Femoral and Vertebral Strength Improvements in Postmenopausal Women With Osteoporosis Treated With Denosumab

Journal of bone and mineral research, 2014-01, Vol.29 (1), p.158-165

2014

Volltextzugriff (PDF)

Romosozumab Enhances Vertebral Bone Structure in Women With Low Bone Density

Journal of bone and mineral research, 2022-02, Vol.37 (2), p.256-264

2022

Volltextzugriff (PDF)

Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults: A Randomized Clinical Trial

JAMA network open, 2020-10, Vol.3 (10), p.e2020836-e2020836

2020

Volltextzugriff (PDF)

Abstract #1164092: Efficacy and Safety of Abaloparatide in Men with Osteoporosis

Endocrine practice, 2022-05, Vol.28 (5), p.S78-S79

2022

Volltextzugriff (PDF)

Subgroup Variations in Bone Mineral Density Response to Zoledronic Acid After Hip Fracture

Journal of bone and mineral research, 2014-12, Vol.29 (12), p.2545-2551

2014

Volltextzugriff (PDF)

Evolocumab lowers LDL-C safely and effectively when self-administered in the at-home setting

SpringerPlus, 2016-03, Vol.5 (1), p.300-300, Article 300

2016

Volltextzugriff (PDF)

Effectiveness of a Novel ω-3 Krill Oil Agent in Patients With Severe Hypertriglyceridemia: A Randomized Clinical Trial

JAMA network open, 2022-01, Vol.5 (1), p.e2141898-e2141898

2022

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(34)
Webseiten
(1)

Sprache

Englisch
(35)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(27)
Humans
(23)
Female
(21)
Aged
(18)
Osteoporosis
(16)
Middle Aged
(15)
Endocrinology & Metabolism
(14)
Male
(11)
Bone Density
(10)
Double-Blind Method
(10)
Aged, 80 And Over
(9)
Bone Density Conservation Agents - Therapeutic Use
(9)
Bone Density - Drug Effects
(7)
Bone Mineral Density
(7)
Fractures
(7)
Antibodies, Monoclonal, Humanized - Therapeutic Use
(6)
Biological And Medical Sciences
(6)
Bone Density Conservation Agents - Administration & Dosage
(6)
Clinical Trials
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1–34)] in postmenopausal osteoporosis

Hospitalization in High Fracture Risk Older Adults with Osteoporosis Using the Safe Functional Motion Test: A Longitudinal Analysis

Antifracture Efficacy and Reduction of Mortality in Relation to Timing of the First Dose of Zoledronic Acid After Hip Fracture

Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study

Bimagrumab to improve recovery after hip fracture in older adults: a multicentre, double-blind, randomised, parallel-group, placebo-controlled, phase 2a/b trial

Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study

Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis

Romosozumab improves lumbar spine BMD and bone strength greater than alendronate as assessed by quantitative computed tomography and finite element analysis in the ARCH trial

Tirzepatide Once Weekly for the Treatment of Obesity

Scores on the safe functional motion test are associated with prevalent fractures and fall history

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

Effects of Romosozumab Compared With Teriparatide on Bone Density and Mass at the Spine and Hip in Postmenopausal Women With Low Bone Mass

Zoledronic acid for prevention and treatment of osteoporosis

Efficacy and safety of transdermal abaloparatide in postmenopausal women with osteoporosis: a randomized study

Early Effects of Abaloparatide on Bone Formation and Resorption Indices in Postmenopausal Women With Osteoporosis

The Efficacy and Safety of Abaloparatide‐SC in Men With Osteoporosis: A Randomized Clinical Trial

Denosumab compared with ibandronate in postmenopausal women previously treated with bisphosphonate therapy: a randomized open-label trial

Zoledronic Acid for the Prevention of Bone Loss in Postmenopausal Women With Low Bone Mass: A Randomized Controlled Trial

Femoral and Vertebral Strength Improvements in Postmenopausal Women With Osteoporosis Treated With Denosumab

Romosozumab Enhances Vertebral Bone Structure in Women With Low Bone Density

Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults: A Randomized Clinical Trial

Abstract #1164092: Efficacy and Safety of Abaloparatide in Men with Osteoporosis

Subgroup Variations in Bone Mineral Density Response to Zoledronic Acid After Hip Fracture

Evolocumab lowers LDL-C safely and effectively when self-administered in the at-home setting

Effectiveness of a Novel ω-3 Krill Oil Agent in Patients With Severe Hypertriglyceridemia: A Randomized Clinical Trial

Suchergebnisse filtern